Easy-to-use tool can identify high- and low-risk metastatic prostate cancer patients earlier

A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
MobiHealthNews

Artera gets FDA de novo nod for AI prostate cancer prognosis tool

California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo authorization by the FDA for its AI tool for prostate cancer ...